CYADY.US ADR Termination

As of the termination time, it is expected that trading of the ADR will cease and the Depository will halt issuance of the ADR. The American Depository Receipt (ADR) of CELYAD ONCOLOGY SA SPONSORED ADR (CYADY.US) is eligible for conversion into the underlying common shares.

The terms to convert the ADR are as follows:
Conversion Ratio: 1 ADR (CYADY) for 1 ORD (CYAD)

Holders are therefore provided with the following choices with respect to their position in the ADR:

Option(1): Take no action and maintain holding of the terminated ADR [Default Option ]

Option(2): Submit ADR for conversion into underlying shares[Need to provide an SSI that can receive stocks]

Handling Fee: 700 USD/each application+ 5 USD/lot cancellation fee (less than 1 lot is counted as 1 lot)

Holders electing to convert the ADR must ensure the account has the necessary trading permissions to hold the underlying asset.

The deadline to make an election to convert the ADR into the underlying security will be 18/10/2023 @16:00 (Hong Kong Time GMT+8)

In the absence of an election, no action will be taken on the position.

Please fill in the following information and use the registered email address of Futu to send an email to cs@futuhk.com.

1. Account Number:
2. Name: (In Chinese or English)
3. Stock code: CYADY.US
4. Options: (1) or (2)
5. Number of shares participating in corporate actions:
6. For Option (2): I agree with the handling fee of 700 USD/each application + 5 USD/each cancellation fee (less than 1 lot is counted as 1 lot)

Note to applicants:
1. If shareholders holding 1 share or less of CYADY.US, they cannot participate in related corporate actions.
2. Option (1) is the default option. We will help clients to choose option 1 if have not received clients’ emails.
3. Once the relevant application is submitted, the stocks participating in the company's actions cannot be traded and the application cannot be withdrawn.
4. This corporate action does not accept additional applications, the maximum number of applications that a client can apply for does not exceed the number of eligible shares it holds.
5. The pending orders and unsettled shares will not be accepted for the time being.
6. Please confirm that the account funds are sufficient to pay the relevant fees of this corporate action. Otherwise, we will not bear any responsibility for the failure of your application.
7. If there is any update, all the information released by the listed company shall prevail.

Helpful？

Yes No